Talphera (TLPH) Preferred Dividend Payments (2022)
Talphera (TLPH) posted Preferred Dividend Payments of -$1.6 million for Q4 2022, down 941.4% on a QoQ basis from $186000.0 in Q3 2022.
Analysis
Talphera (TLPH) Preferred Dividend Payments (2022) Analysis & Trends
Talphera has reported Preferred Dividend Payments for 1 years, with the latest figure at -$1.6 million in Q4 2022.
- On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to -$1.6 million in Q4 2022; TTM through Dec 2023 was -$1.6 million, a 125.52% decrease from a year earlier, with the FY2022 full-year figure at $5.2 million, changed N/A from the prior year.
- Preferred Dividend Payments was -$1.6 million for Q4 2022 at Talphera, down from $186000.0 in the prior quarter.
- The five-year high for Preferred Dividend Payments was $7.5 million in Q2 2022, with the low at -$1.6 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.02 Bn | 176.84 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 131.54 Bn | 123.69 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.96 Bn | 73.96 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.23 Bn | 55.04 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.85 Bn | 48.72 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.13 Bn | 29.82 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.88 Bn | 30.59 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.23 Bn | 29.23 Bn | 1.16 Mn | - |
| 10 | Talphera | 93.28 Mn | 93.28 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -1.57 Mn |
| Sep 30, 2022 | 186,000.00 |
| Jun 30, 2022 | 7.51 Mn |